Skin Ulcer
22
3
3
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.6%
3 terminated out of 22 trials
66.7%
-19.8% vs benchmark
18%
4 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (22)
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
A Real-World Registry of Chronic Wounds and Ulcers
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
IDEAL SKIIN CARES Bundle to Prevent Pressure Injury
Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHO-recommended Wound Management in West Africa
Low Concentration ALA-PDT in Treatment of Skin Ulcer
Epidermal Grafting in Wound Healing
Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Support Surfaces to Prevent Pressure Injuries
Washcloths Effectiveness in Preventing Pressure Ulcers
Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts
The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study
Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
Treatment of Hypertensive Leg Ulcer by Adipose Tissue Grafting
Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX